dacarbazine has been researched along with Clear Cell Sarcoma of Soft Tissue in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, L; Hu, C; Zhang, X | 1 |
Fujimoto, M; Hiraga, M; Kiyosawa, T; Murakami, T; Murata, S; Nakagawa, H; Ohtsuki, M | 1 |
Altinok, M; Atalay, C; Irkkan, C; Pak, I | 1 |
Carmichael, J; Ganesan, TA; Harris, AL; Philip, PA; Tonkin, K | 1 |
1 trial(s) available for dacarbazine and Clear Cell Sarcoma of Soft Tissue
Article | Year |
---|---|
A phase II study of high-dose hydroxyurea and dacarbazine (DTIC) in the treatment of metastatic malignant melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Dacarbazine; Female; Gastrointestinal Neoplasms; Humans; Hydroxyurea; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Sarcoma, Clear Cell; Treatment Outcome | 1994 |
3 other study(ies) available for dacarbazine and Clear Cell Sarcoma of Soft Tissue
Article | Year |
---|---|
A giant clear cell sarcoma on right scapular: A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Epirubicin; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Sarcoma, Clear Cell; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2016 |
Complete remission of metastatic clear cell sarcoma with DAV chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Sarcoma, Clear Cell; Skin Neoplasms; Treatment Outcome; Vincristine | 2003 |
Gastroduodenal metastases in a clear cell sarcoma patient.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Biopsy, Fine-Needle; Cisplatin; Dacarbazine; Duodenal Neoplasms; Humans; Male; Middle Aged; Sarcoma, Clear Cell; Stomach Neoplasms; Time Factors; Treatment Outcome | 2003 |